CLESNUVO Trademark
Trademark Overview
On Wednesday, September 27, 2023, a trademark application was filed for CLESNUVO with the United States Patent and Trademark Office. The USPTO has given the CLESNUVO trademark a serial number of 98200268. The federal status of this trademark filing is PUBLICATION/ISSUE REVIEW COMPLETE as of Thursday, November 21, 2024. This trademark is owned by Rosemont Pharmaceuticals Limited. The CLESNUVO trademark is filed in the Pharmaceutical Products category with the following description:
Pharmaceutical and medical preparations for patients suffering from dysphagia and conditions requiring medication in liquid form
for the treatment of viral, bacterial, parasitic and fungal diseases and infections; oral liquid medicines for the treatment of viral,
bacterial, parasitic and fungal diseases and infections; drugs for medical purposes in the nature of medicines for the treatment of
viral, bacterial, parasitic and fungal diseases and infections; substances, drugs, medicines and medical preparations, namely,
drug delivery agents consisting of compounds in the form of oral liquid medicines, oral suspensions, dispersible and soluble
tablets, and powders to be consumed in liquid form, that facilitate the delivery of a wide range of pharmaceuticals; substances,
drugs, medicines and medical preparations, namely, drug delivery agents consisting of compounds in the form of oral liquid
medicines, oral suspensions, dispersible and soluble tablets, and powders to be consumed in liquid f...
General Information
| Serial Number | 98200268 |
| Word Mark | CLESNUVO |
| Filing Date | Wednesday, September 27, 2023 |
| Status | 681 - PUBLICATION/ISSUE REVIEW COMPLETE |
| Status Date | Thursday, November 21, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, December 10, 2024 |
Trademark Statements
| Goods and Services | Pharmaceutical and medical preparations for patients suffering from dysphagia and conditions requiring medication in liquid form
for the treatment of viral, bacterial, parasitic and fungal diseases and infections; oral liquid medicines for the treatment of viral,
bacterial, parasitic and fungal diseases and infections; drugs for medical purposes in the nature of medicines for the treatment of
viral, bacterial, parasitic and fungal diseases and infections; substances, drugs, medicines and medical preparations, namely,
drug delivery agents consisting of compounds in the form of oral liquid medicines, oral suspensions, dispersible and soluble
tablets, and powders to be consumed in liquid form, that facilitate the delivery of a wide range of pharmaceuticals; substances,
drugs, medicines and medical preparations, namely, drug delivery agents consisting of compounds in the form of oral liquid
medicines, oral suspensions, dispersible and soluble tablets, and powders to be consumed in liquid form, that facilitate the
delivery of anti-infective agents, antineoplastic agents, cardiovascular agents, central nervous system agents, coagulation
modifiers, gastrointestinal agents, genitourinary tract agents, psychotherapeutic agents and metabolic agents |
Classification Information
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, October 11, 2023 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | Rosemont Pharmaceuticals Limited |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 99 - Other |
| Address | Leeds LS119XE |
Trademark Events
| Event Date | Event Description |
| Saturday, September 30, 2023 | NEW APPLICATION ENTERED |
| Wednesday, October 11, 2023 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Monday, May 20, 2024 | ASSIGNED TO EXAMINER |
| Tuesday, June 4, 2024 | NON-FINAL ACTION WRITTEN |
| Tuesday, June 4, 2024 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Tuesday, June 4, 2024 | NON-FINAL ACTION E-MAILED |
| Wednesday, July 17, 2024 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Thursday, October 24, 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Thursday, October 24, 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Thursday, October 24, 2024 | ASSIGNED TO LIE |
| Friday, November 15, 2024 | APPROVED FOR PUB - PRINCIPAL REGISTER |
